Contributing to global tuberculosis control through innovative research and training:
From Bench to Bedside and Beyond.

Where we Work

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

IMPORTANCE: Three months of a once-weekly combination of rifapentine and isoniazid for treatment of latent tuberculosis...

Objective: The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident...

Tuberculosis (TB) remains disproportionately concentrated among the poor, yet known determinants of TB reactivation may fail to...

There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active...

Nearly 20 years after the World Health Organization declared tuberculosis (TB) a global public health emergency, TB...